Millard–Gubler syndrome

From WikiMD's Food, Medicine & Wellnesspedia

Millard–Gubler syndrome (also known as ventral pontine syndrome) is a rare medical condition that affects the nervous system. It is characterized by a set of symptoms that result from damage to specific areas of the brain, particularly the pons. The syndrome is named after Auguste Millard and Adolphe-Marie Gubler, the French physicians who first described it in the 19th century.

Symptoms[edit | edit source]

The symptoms of Millard–Gubler syndrome can vary widely, but typically include:

  • Facial paralysis: This is often the most noticeable symptom. It results from damage to the facial nerve, which controls the muscles of the face.
  • Abducens palsy: This is a weakness or paralysis of the eye muscle that controls lateral movement, causing the eye to turn inward.
  • Hemiplegia: This is a paralysis of one side of the body, usually the side opposite the damaged area of the brain.

Causes[edit | edit source]

Millard–Gubler syndrome is caused by a lesion in the ventral part of the pons, a part of the brainstem. This can occur due to a variety of conditions, including:

Diagnosis[edit | edit source]

Diagnosis of Millard–Gubler syndrome is based on the presence of the characteristic symptoms and is confirmed by imaging studies such as MRI or CT scan.

Treatment[edit | edit source]

Treatment for Millard–Gubler syndrome is primarily supportive and aims to manage the symptoms. This may include:

Prognosis[edit | edit source]

The prognosis for Millard–Gubler syndrome depends on the underlying cause and the extent of the brain damage. Some people may recover fully, while others may have long-term or permanent disability.

See also[edit | edit source]

References[edit | edit source]


Millard–Gubler syndrome Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Admin, Prab R. Tumpati, MD